Author Archives: Thomas Payne

TScan Therapeutics Announces Exercise of Underwriters’ Option to Purchase Additional Shares

By

TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting

By

TScan Therapeutics Announces Closing of Upsized Public Offering

By

TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering

By

TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering

By

TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities

By

TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer

By

TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference

By

TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

By

TScan Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

By